ArticleBone marrow transplantation2025
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.
Gagan Raju et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.